Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 8Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 2Obesity 2Neoplasms 2Head and Neck Neoplasms 2Triple Negative Breast Neoplasms 1Tracheal Diseases 1TP53 Y220C Mutation 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Overweight 1Osteosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma 1Meningioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1

Interventions

Transcranial Direct Current Stimulation 2Exercise 2mazdutide 1lime 1fasudil 1enzalutamide 1Time 1Tablets 1Standard of Care 1Referral and Consultation 1Ramipril 1Radiosurgery 1Prednisone 1Population Groups 1Palliative Care 1Organization and Administration 1Modafinil 1Methods 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Low-Level Light Therapy 1Hormones 1Health 1Gonadotropin-Releasing Hormone 1Electroencephalography 1Drug Delivery Systems 1Data Collection 1Anesthesia, General 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Tablets × 1 year × Clear all
NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting
140 enrolled
CNS

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡